Stimulant Still Available for Sale Despite FDA Action

DMAA marketed as a dietary supplement

WEDNESDAY, Dec. 5 (HealthDay News) -- Products containing 1,3-dimethylamylamine (DMAA), a stimulant marketed as a dietary supplement in the United States, are still available for sale despite a warning from the U.S. Food and Drug Administration, according to a research letter published online Dec. 3 in the Archives of Internal Medicine.

Philip J. Gregory, Pharm.D., from Creighton University in Omaha, Neb., surveyed whether 16 products containing DMAA were available for sale through online retailers as of May 17, 2012. The FDA had sent warning letters to the manufacturers of these products on April 27, 2012, stating that the products were considered adulterated because DMAA is considered a new dietary ingredient. A manufacturer of a new dietary ingredient is required to submit documentation demonstrating the expectation of safety; if this documentation is not received, the FDA considers the product to be an unapproved drug.

Gregory found that all 16 products were still available for sale, either through online retailers or directly from the manufacturer. None of the Web sites noted that the products were illegal, adulterated, and generally not permitted for sale.

"Despite this warning, all of the products in question are still readily available," Gregory concludes. "This suggests that the FDA's warning process may do little to nothing to stem the significant public health risk posed by this potentially dangerous ingredient."

Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Blunt Chest Trauma
Journal of Trauma Nursing, November/December 2014
Expires: 12/31/2016 CE:2 $21.95


The School Age Child with Congenital Heart Disease
MCN, The American Journal of Maternal/Child Nursing, January/February 2015
Expires: 2/28/2017 CE:2.5 $24.95


Understanding multiple myeloma
Nursing Made Incredibly Easy!, January/February 2015
Expires: 2/28/2017 CE:2 $21.95


More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles

Comprehensive Care: Looking Beyond the Presenting Problem
Journal of Christian Nursing, January/March 2015
Free access will expire on March 2, 2015.


Pain and Alzheimer dementia: A largely unrecognized problem
Nursing Made Incredibly Easy!, January/February 2015
Free access will expire on February 16, 2015.


Glycemic control in hospitalized patients
Nursing2015 Critical Care, January 2015
Free access will expire on February 16, 2015.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events